Amarin's Vascepa prevents second and third heart attacks in analysis STATWith Vascepa, first heart problems were cut by 25 percent, second ones by 32 percent, third events by 31 percent, and fourth events by 48 percent.View full coverage on Google News

BING NEWS:
  • Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
    NEW ORLEANS — A new analysis of a large study unveiled last November shows that Vascepa, a fish-oil-derived drug sold by Amarin (AMRN) Pharmaceuticals, reduces second and third heart attacks as well ...
    03/18/2019 - 2:04 am | View Link
  • Archived chat: Breaking down Amarin’s highly anticipated REDUCE-IT trial
    Vascepa sales have been modest, however, because Amarin lacks scientific proof that reducing this fat in blood prevents heart attacks, stroke ... and life science coverage and analysis. Our ...
    07/18/2018 - 6:49 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News